<DOC>
	<DOCNO>NCT00819156</DOCNO>
	<brief_summary>The purpose trial evaluate safety efficacy degarelix compare six different dos . The patient participate trial treat degarelix every month year . During treatment patient visit clinic investigation . Blood sample testosterone , dihydrotestosterone , luteinizing hormone , follicle stimulate hormone , Prostate Specific Antigen take analyse throughout trial .</brief_summary>
	<brief_title>Dose Finding Trial With New Treatment ( Degarelix ) Prostate Cancer</brief_title>
	<detailed_description>Degarelix FDA regulate time trial . After completion trial degarelix approve FDA thus FDA regulate intervention .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Written inform consent prior study related procedure Proven prostate cancer need endocrine treatment , except neoadjuvant hormonal therapy , include patient rise PSA prostatectomy radiotherapy ECOG score equal 2 Testosterone level within agespecific normal range PSA value equal 2 ng/ml Life expectancy least 6 month Previous current hormonal treatment prostate cancer Recent current treatment drug modify testosterone level Candidate curative treatment prostatectomy radiotherapy History severe asthma , anaphylactic reaction , angioedema , angioneurotic oedema Quincke 's Oedema Hypersensitivity towards component degarelix mannitol Cancer disease within last 5 year except prostate cancer skin cancer Signs liver impairment show elevated serum ALT serum bilirubin Known hepatic disease Other laboratory abnormality judge investigator would interfere patient participation trial evaluation trial result Clinically significant disorder include excessive alcohol drug abuse may interfere trial participation influence conclusion trial judge investigator Mental incapacity language barrier preclude adequate understanding cooperation Having receive investigational product within last 12 week precede trial Previous participation trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>